Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04919525 · ClinicalTrials.gov registry record · NA
Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial
A NA study of Fibromyalgia, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04919525: Completed NA study of Fibromyalgia, sponsored by Icahn School of Medicine at Mount Sinai.
NCT04919525 is a NA study of Fibromyalgia that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 11 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04919525, a NA study of Fibromyalgia, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the feasibility of gamified sensory perceptual training in people with fibromyalgia. The primary aim is to determine the feasibility of at-home somatosensorial training for people with fibromyalgia. The researchers are determining the feasibility of using this device to decrease chronic neuropathic pain in people with fibromyalgia. The secondary aim is to survey participants' subjective report of clinical change after this program.
Primary Outcome
Retention rates to assess the feasibility of at-home somatosensorial training technology for people with fibromyalgia
Conditions Studied
Interventions
- DEVICE TrainPain
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-03-18 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
What the finished NCT04919525 record still lists
NCT04919525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which TrainPain is the first listed.
NCT04919525 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04919525 about?
NCT04919525 is a clinical study titled "Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial". The purpose of this study is to determine the feasibility of gamified sensory perceptual training in people with fibromyalgia. The primary aim is to determine the feasibility of at-home somatosensorial training for people with fibromyalgia. The researchers are determining the feasibility of using th...
What is the current status of trial NCT04919525?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-03-18. Estimated completion is 2022-06-03.
What conditions does trial NCT04919525 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT04919525?
The interventions under investigation include: TrainPain (DEVICE).
Who is sponsoring clinical trial NCT04919525?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04919525 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04919525's enrollment target sits among peer trials
11 74th of 76 higher than 3 of 76 other Fibromyalgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Effects of Breathing and Attention Training (BAT) on Pain Modulation
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Fibromyalgia Sleep A to ZZZ Study
RECRUITING · NA
-
Explosive Synchronization of Brain Network Activity in Chronic Pain
RECRUITING · NA
-
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI